cAMP regulation of airway smooth muscle function

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 1, 2013, Pages 112-120

  Billington, Charlotte K ^a   Ojo, Oluwaseun O ^b   Penn, Raymond B ^c   Ito, Satoru ^d  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

Adrenoceptor; Airway smooth muscle; Asthma; CAMP; COPD; Epac; Protein kinase A

Indexed keywords

5 (4 ACETAMIDOPHENYL) 2(1H) PYRAZINONE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ B2 RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM ION; CORTICOSTEROID; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; ENDOTHELIN A RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLYCERYL TRINITRATE; HISTAMINE H1 RECEPTOR; ION CHANNEL; LONG ACTING BETA AGONIST; PHOSPHODIESTERASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV INHIBITOR; PHOSPHOLIPASE C; PROSTAGLANDIN E2; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; ROLIPRAM; SALBUTAMOL; SARCOPLASMIC RETICULUM ION CHANNEL; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZAPRINAST;

AIRWAY; AIRWAY SMOOTH MUSCLE CELL; ARTICLE; ASTHMA; BRONCHOSPASM; CALCIUM CELL LEVEL; CELL FUNCTION; CELL GROWTH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DISEASE CONTROL; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MONOTHERAPY; OSCILLATION; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE RELAXATION;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANIMALS; ASTHMA; BRONCHOCONSTRICTION; CYCLIC AMP; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; MUSCLE, SMOOTH; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, ADRENERGIC, BETA-2;

EID: 84873159987     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.05.007     Document Type: Article

References (141)

1. Salathe M. Effects of β-agonists on airway epithelial cells. J Allergy Clin Immunol 2002, 110:S275-S281.
2. Billington C.K., Penn R.B. Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res 2003, 4:2.
3. Giembycz M.A., Kaur M., Leigh R., Newton R. A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids. Br J Pharmacol 2008, 153:1090-1104.
4. Spina D. PDE4 inhibitors: current status. Br J Pharmacol 2008, 155:308-315.
5. Diamant Z., Spina D. PDE4-inhibitors: a novel, targeted therapy for obstructive airways disease. Pulm Pharmacol Ther 2011, 24:353-360.
6. Page C., Spina D. Selective PDE inhibitors as novel treatments for respiratory diseases. Curr Opin Pharmacol 2012.
7. Beavo J.A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995, 75:725-748.
8. Torphy T.J., Undem B.J., Cieslinski L.B., Luttmann M.A., Reeves M.L., Hay D.W. Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle. J Pharmacol Exp Ther 1993, 265:1213-1223.
9. Rabe K.F., Tenor H., Dent G., Schudt C., Liebig S., Magnussen H. Phosphodiesterase isozymes modulating inherent tone in human airways: identification and characterization. Am J Physiol 1993, 264:L458-L464.
10. Billington C.K., Le Jeune I.R., Young K.W., Hall I.P. A major functional role for phosphodiesterase 4D5 in human airway smooth muscle cells. Am J Respir Cell Mol Biol 2008, 38:1-7.
11. Trian T., Burgess J.K., Niimi K., Moir L.M., Ge Q., Berger P., et al. β2-agonist induced cAMP is decreased in asthmatic airway smooth muscle due to increased PDE4D. PLoS One 2011, 6:e20000.
12. 2+ sensitivity of airway smooth muscle contraction through a mechanism distinct from inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 2004, 287:L641-L648.
13. Ito Y., Takagi K., Tomita T. Relaxant actions of isoprenaline on guinea-pig isolated tracheal smooth muscle. Br J Pharmacol 1995, 116:2738-2742.
14. 2+ homeostasis and structural and functional remodelling of airway smooth muscle in asthma. Thorax 2010, 65:547-552.
15. 2+ in β-adrenergic action on airway smooth muscle. Clin Exp Allergy 2006, 36:183-191.
16. Ba M., Singer C.A., Tyagi M., Brophy C., Baker J.E., Cremo C., et al. HSP20 phosphorylation and airway smooth muscle relaxation. Cell Health Cytoskelet 2009, 2009:27-42.
17. Komalavilas P., Penn R.B., Flynn C.R., Thresher J., Lopes L.B., Furnish E.J., et al. The small heat shock-related protein, HSP20, is a cAMP-dependent protein kinase substrate that is involved in airway smooth muscle relaxation. Am J Physiol Lung Cell Mol Physiol 2008, 294:L69-L78.
18. Yan H., Deshpande D.A., Misior A.M., Miles M.C., Saxena H., Riemer E.C., et al. Anti-mitogenic effects of beta-agonists and PGE2 on airway smooth muscle are PKA dependent. FASEB J 2011, 25:389-397.
19. 2-Adrenergic receptor agonists modulate human airway smooth muscle cell migration via vasodilator-stimulated phosphoprotein. Am J Respir Cell Mol Biol 2012, 46:48-54.
20. Spicuzza L., Belvisi M.G., Birrell M.A., Barnes P.J., Hele D.J., Giembycz M.A. Evidence that the anti-spasmogenic effect of the β-adrenoceptor agonist, isoprenaline, on guinea-pig trachealis is not mediated by cyclic AMP-dependent protein kinase. Br J Pharmacol 2001, 133:1201-1212.
21. Jiang H., Colbran J.L., Francis S.H., Corbin J.D. Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J Biol Chem 1992, 267:1015-1019.
22. Torphy T.J., Freese W.B., Rinard G.A., Brunton L.L., Mayer S.E. Cyclic nucleotide-dependent protein kinases in airway smooth muscle. J Biol Chem 1982, 257:11609-11616.
23. Gruetter C.A., Childers C.E., Bosserman M.K., Lemke S.M., Ball J.G., Valentovic M.A. Comparison of relaxation induced by glyceryl trinitrate, isosorbide dinitrate, and sodium nitroprusside in bovine airways. Am Rev Respir Dis 1989, 139:1192-1197.
24. de Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A., et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998, 396:474-477.
25. Gloerich M., Bos J.L. Epac: defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol 2010, 50:355-375.
26. Grandoch M., Roscioni S.S., Schmidt M. The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function. Br J Pharmacol 2010, 159:265-284.
27. Kassel K.M., Wyatt T.A., Panettieri R.A., Toews M.L. Inhibition of human airway smooth muscle cell proliferation by β2-adrenergic receptors and cAMP is PKA independent: evidence for EPAC involvement. Am J Physiol Lung Cell Mol Physiol 2008, 294:L131-L138.
28. Billington C.K., Hall I.P. Novel cyclic AMP signalling paradigms: therapeutic implications for airway disease. Br J Pharmacol 2012, 166:401-410.
29. Giembycz M.A., Newton R. Beyond the dogma: novel β2-adrenoceptor signalling in the airways. Eur Respir J 2006, 27:1286-1306.
30. Borland G., Smith B.O., Yarwood S.J. EPAC proteins transduce diverse cellular actions of cAMP. Br J Pharmacol 2009, 158:70-86.
31. Roscioni S.S., Maarsingh H., Elzinga C.R., Schuur J., Menzen M., Halayko A.J., et al. Epac as a novel effector of airway smooth muscle relaxation. J Cell Mol Med 2011, 15:1551-1563.
32. Zieba B.J., Artamonov M.V., Jin L., Momotani K., Ho R., Franke A.S., et al. The cAMP-responsive Rap1 guanine nucleotide exchange factor, Epac, induces smooth muscle relaxation by down-regulation of RhoA activity. J Biol Chem 2011, 286:16681-16692.
33. Roscioni S.S., Kistemaker L.E., Menzen M.H., Elzinga C.R., Gosens R., Halayko A.J., et al. PKA and Epac cooperate to augment bradykinin-induced interleukin-8 release from human airway smooth muscle cells. Respir Res 2009, 10:88.
34. i-coupled γ-aminobutyric acid-B receptors cross-regulate phospholipase C and calcium in airway smooth muscle. Am J Respir Cell Mol Biol 2011, 45:1232-1238.
35. Gallos G., Gleason N.R., Virag L., Zhang Y., Mizuta K., Whittington R.A., et al. Endogenous γ-aminobutyric acid modulates tonic guinea pig airway tone and propofol-induced airway smooth muscle relaxation. Anesthesiology 2009, 110:748-758.
36. An S.S., Bai T.R., Bates J.H., Black J.L., Brown R.H., Brusasco V., et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J 2007, 29:834-860.
37. Deshpande D.A., Penn R.B. Targeting G protein-coupled receptor signaling in asthma. Cell Signal 2006, 18:2105-2120.
38. 2+ signalling and contraction of airway smooth muscle by cyclic AMP-dependent mechanisms. Br J Pharmacol 1996, 117:419-426.
39. Madison J.M., Brown J.K. Differential inhibitory effects of forskolin, isoproterenol, and dibutyryl cyclic adenosine monophosphate on phosphoinositide hydrolysis in canine tracheal smooth muscle. J Clin Invest 1988, 82:1462-1465.
40. Smith N., Browning C.A., Duroudier N., Stewart C., Peel S., Swan C., et al. Salmeterol and cytokines modulate inositol-phosphate signalling in human airway smooth muscle cells via regulation at the receptor locus. Respir Res 2007, 8:68.
41. Holden N.S., Bell M.J., Rider C.F., King E.M., Gaunt D.D., Leigh R., et al. Beta2-Adrenoceptor agonist-induced RGS2 expression is a genomic mechanism of bronchoprotection that is enhanced by glucocorticoids. Proc Natl Acad Sci U S A 2011, 108:19713-19718.
42. 2+ influx pathway activated by mechanical stretch in human airway smooth muscle cells. Am J Respir Cell Mol Biol 2008, 38:407-413.
43. 2+ entry by Rho-kinase in tracheal smooth muscle. Am J Respir Cell Mol Biol 2002, 26:491-498.
44. Perez-Zoghbi J.F., Karner C., Ito S., Shepherd M., Alrashdan Y., Sanderson M.J. Ion channel regulation of intracellular calcium and airway smooth muscle function. Pulm Pharmacol Ther 2009, 22:388-397.
45. Corteling R.L., Li S., Giddings J., Westwick J., Poll C., Hall I.P. Expression of transient receptor potential C6 and related transient receptor potential family members in human airway smooth muscle and lung tissue. Am J Respir Cell Mol Biol 2004, 30:145-154.
46. Murray R.K., Kotlikoff M.I. Receptor-activated calcium influx in human airway smooth muscle cells. J Physiol 1991, 435:123-144.
47. Peel S.E., Liu B., Hall I.P. ORAI and store-operated calcium influx in human airway smooth muscle cells. Am J Respir Cell Mol Biol 2008, 38:744-749.
48. 2+ sensitization and mobilization by MCh in tracheal smooth muscle. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1218-L1224.
49. Peel S.E., Liu B., Hall I.P. A key role for STIM1 in store operated calcium channel activation in airway smooth muscle. Respir Res 2006, 7:119.
50. 2+ influx in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2006, 290:L278-L283.
51. 2+ regulation in airway smooth muscle contraction: do the data contradict dogma?. Am J Physiol Lung Cell Mol Physiol 2002, 282:L1161-L1178.
52. 2+ sensitivity of airway smooth muscle cells in murine lung slices. Am J Physiol Lung Cell Mol Physiol 2006, 291:L208-L221.
53. Yoshida Y., Imai S. Structure and function of inositol 1,4,5-trisphosphate receptor. Jpn J Pharmacol 1997, 74:125-137.
54. Prakash Y.S., van der Heijden H.F., Kannan M.S., Sieck G.C. Effects of salbutamol on intracellular calcium oscillations in porcine airway smooth muscle. J Appl Physiol 1997, 82:1836-1843.
55. 2+-uptake mediate adrenergic relaxation of airway smooth muscle. Am J Respir Cell Mol Biol 2004, 30:548-554.
56. Ca channels in airway smooth muscle cells by endogenous protein kinase A. Am J Physiol 1996, 271:L100-L105.
57. Ca channels in airway smooth muscle by cAMP-dependent and -independent mechanisms. J Clin Invest 1994, 93:371-379.
58. Zhou X.B., Wulfsen I., Utku E., Sausbier U., Sausbier M., Wieland T., et al. Dual role of protein kinase C on BK channel regulation. Proc Natl Acad Sci U S A 2010, 107:8005-8010.
59. 2+ channels by cAMP and cGMP in vascular smooth muscle cells. Circ Res 1993, 73:1128-1137.
60. 2+ reuptake in human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2009, 297:L26-L34.
61. 2+ ATPase (SERCA) expression contributes to airway remodelling in bronchial asthma. Proc Natl Acad Sci U S A 2009, 106:10775-10780.
62. 2 agonist formoterol and inflammatory cytokines suppress SERCA-2 expression in human airway smooth muscle. Am J Respir Crit Care Med 2010, A5302.
63. 2+-ATPase protein and activity. Am J Physiol Heart Circ Physiol 2008, 294:H2587-H2595.
64. 2+ signaling and sensitivity. Proc Am Thorac Soc 2008, 5:23-31.
65. 2+ sensitivity. Am J Respir Cell Mol Biol 2010, 43:179-191.
66. 2+ signaling of mouse airway smooth muscle cells. Am J Respir Cell Mol Biol 2010, 42:373-381.
67. Schaafsma D., Gosens R., Bos I.S., Meurs H., Zaagsma J., Nelemans S.A. Allergic sensitization enhances the contribution of Rho-kinase to airway smooth muscle contraction. Br J Pharmacol 2004, 143:477-484.
68. Penn R.B., Benovic J.L. Regulation of heterotrimeric G protein signaling in airway smooth muscle. Proc Am Thorac Soc 2008, 5:47-57.
69. 2+ sensitivity and modulates BK channels in porcine tracheal smooth muscle. Br J Pharmacol 2003, 140:939-947.
70. Eto M., Senba S., Morita F., Yazawa M. Molecular cloning of a novel phosphorylation-dependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle. FEBS Lett 1997, 410:356-360.
71. Morin C., Sirois M., Echave V., Rousseau E. CPI-17 silencing-reduced responsiveness in control and TNF-alpha-treated human bronchi. Am J Respir Cell Mol Biol 2008, 39:638-643.
72. Hirshman C.A., Zhu D., Panettieri R.A., Emala C.W. Actin depolymerization via the beta-adrenoceptor in airway smooth muscle cells: a novel PKA-independent pathway. Am J Physiol Cell Physiol 2001, 281:C1468-C1476.
73. 2. Trends Immunol 2004, 25:40-46.
74. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294:1871-1875.
75. 2 enhances interleukin-8 production via EP4 receptor in human pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 2012, 302:L266-L273.
76. Goncharova E.A., Billington C.K., Irani C., Vorotnikov A.V., Tkachuk V.A., Penn R.B., et al. Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration. Am J Respir Cell Mol Biol 2003, 29:19-27.
77. 2-adrenoceptor ligands in the treatment of asthma. Br J Pharmacol 2011, 163:18-28.
78. 2 in cultured guinea pig tracheal smooth muscle cells. Am J Physiol 1994, 266:L131-L137.
79. 2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A. Am J Physiol Lung Cell Mol Physiol 2008, 295. L505-L514.
80. 2+ concentrations in human airway smooth muscle cells. Eur J Pharmacol 2011, 659:72-78.
81. 2+ sensitization in tracheal smooth muscle. Am J Respir Cell Mol Biol 2001, 25:291-298.
82. 2 might be mediated by increased numbers of E-prostanoid receptors. J Allergy Clin Immunol 2004, 113:876-881.
83. 1 phase of the cell cycle: role of proteasome degradation of cyclin D1. Mol Pharmacol 1999, 56:1079-1086.
84. Tomlinson P.R., Wilson J.W., Stewart A.G. Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels. Biochem Pharmacol 1995, 49:1809-1819.
85. Ammit A.J., Hoffman R.K., Amrani Y., Lazaar A.L., Hay D.W., Torphy T.J., et al. Tumor necrosis factor-α-induced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate. Am J Respir Cell Mol Biol 2000, 23:794-802.
86. Narumiya S., Sugimoto Y., Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999, 79:1193-1226.
87. Clarke D.L., Belvisi M.G., Smith S.J., Hardaker E., Yacoub M.H., Meja K.K., et al. Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol 2005, 288:L238-L250.
88. s-coupled receptors in smooth muscle exhibit differential susceptibility to GRK2/3-mediated desensitization. Biochemistry 2008, 47:9279-9288.
89. Ndukwu I.M., White S.R., Leff A.R., Mitchell R.W. EP1 receptor blockade attenuates both spontaneous tone and PGE2-elicited contraction in guinea pig trachealis. Am J Physiol 1997, 273:L626-L633.
90. 2-adrenergic receptors within a unique heterodimeric complex. J Clin Invest 2006, 116:1400-1409.
91. Norel X., Walch L., Labat C., Gascard J.P., Dulmet E., Brink C. Prostanoid receptors involved in the relaxation of human bronchial preparations. Br J Pharmacol 1999, 126:867-872.
92. Tilley S.L., Hartney J.M., Erikson C.J., Jania C., Nguyen M., Stock J., et al. Receptors and pathways mediating the effects of prostaglandin E2 on airway tone. Am J Physiol Lung Cell Mol Physiol 2003, 284:L599-L606.
93. 4 receptor as a new target for bronchodilator therapy. Thorax 2011, 66:1029-1035.
94. 4) agonists: potent dilators of human bronchi and future asthma therapy?. Pulm Pharmacol Ther 2012, 25:115-118.
95. Misior A.M., Yan H., Pascual R.M., Deshpande D.A., Panettieri R.A., Penn R.B. Mitogenic effects of cytokines on smooth muscle are critically dependent on protein kinase A and are unmasked by steroids and cyclooxygenase inhibitors. Mol Pharmacol 2008, 73:566-574.
96. Guo M., Pascual R.M., Wang S., Fontana M.F., Valancius C.A., Panettieri R.A., et al. Cytokines regulate β-2-adrenergic receptor responsiveness in airway smooth muscle via multiple PKA- and EP2 receptor-dependent mechanisms. Biochemistry 2005, 44:13771-13782.
97. Nials A.T., Coleman R.A., Johnson M., Magnussen H., Rabe K.F., Vardey C.J. Effects of beta-adrenoceptor agonists in human bronchial smooth muscle. Br J Pharmacol 1993, 110:1112-1116.
98. Carlin S.M., Roth M., Black J.L. Urokinase potentiates PDGF-induced chemotaxis of human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2003, 284:L1020-L1026.
99. Parameswaran K., Cox G., Radford K., Janssen L.J., Sehmi R., O'Byrne P.M. Cysteinyl leukotrienes promote human airway smooth muscle migration. Am J Respir Crit Care Med 2002, 166:738-742.
100. Hirakawa M., Karashima Y., Watanabe M., Kimura C., Ito Y., Oike M. Protein kinase A inhibits lysophosphatidic acid-induced migration of airway smooth muscle cells. J Pharmacol Exp Ther 2007, 321:1102-1108.
101. 2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 2002, 360:1293-1299.
102. Billington C.K., Joseph S.K., Swan C., Scott M.G., Jobson T.M., Hall I.P. Modulation of human airway smooth muscle proliferation by type 3 phosphodiesterase inhibition. Am J Physiol 1999, 276:L412-L419.
103. Lazaar A.L., Panettieri R.A. Airway smooth muscle: a modulator of airway remodeling in asthma. J Allergy Clin Immunol 2005, 116:488-495. quiz 96.
104. Johnson P.R., Roth M., Tamm M., Hughes M., Ge Q., King G., et al. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001, 164:474-477.
105. Hirst S.J., Martin J.G., Bonacci J.V., Chan V., Fixman E.D., Hamid Q.A., et al. Proliferative aspects of airway smooth muscle. J Allergy Clin Immunol 2004, 114:S2-17.
106. Madison J.M. Migration of airway smooth muscle cells. Am J Respir Cell Mol Biol 2003, 29:8-11.
107. Gerthoffer W.T. Migration of airway smooth muscle cells. Proc Am Thorac Soc 2008, 5:97-105.
108. Roscioni S.S., Prins A.G., Elzinga C.R., Menzen M.H., Dekkers B.G., Halayko A.J., et al. Protein kinase A and the exchange protein directly activated by cAMP (Epac) modulate phenotype plasticity in human airway smooth muscle. Br J Pharmacol 2011, 164:958-969.
109. Gosens R., Roscioni S.S., Dekkers B.G., Pera T., Schmidt M., Schaafsma D., et al. Pharmacology of airway smooth muscle proliferation. Eur J Pharmacol 2008, 585:385-397.
110. Belvisi M.G., Saunders M., Yacoub M., Mitchell J.A. Expression of cyclo-oxygenase-2 in human airway smooth muscle is associated with profound reductions in cell growth. Br J Pharmacol 1998, 125:1102-1108.
111. Pascual R.M., Billington C.K., Hall I.P., Panettieri R.A., Fish J.E., Peters S.P., et al. Mechanisms of cytokine effects on G protein-coupled receptor-mediated signaling in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2001, 281:L1425-L1435.
112. Pascual R.M., Carr E.M., Seeds M.C., Guo M., Panettieri R.A., Peters S.P., et al. Regulatory features of interleukin-1beta-mediated prostaglandin E2 synthesis in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2006, 290:L501-L508.
113. Krause M., Dent E.W., Bear J.E., Loureiro J.J., Gertler F.B. Ena/VASP proteins: regulators of the actin cytoskeleton and cell migration. Annu Rev Cell Dev Biol 2003, 19:541-564.
114. Howarth P.H., Knox A.J., Amrani Y., Tliba O., Panettieri R.A., Johnson M. Synthetic responses in airway smooth muscle. J Allergy Clin Immunol 2004, 114:S32-S50.
115. Tliba O., Panettieri R.A. Noncontractile functions of airway smooth muscle cells in asthma. Annu Rev Physiol 2009, 71:509-535.
116. Lazzeri N., Belvisi M.G., Patel H.J., Yacoub M.H., Chung K.F., Mitchell J.A. Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy. Am J Respir Cell Mol Biol 2001, 24:44-48.
117. Pang L., Knox A.J. Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells. Am J Respir Cell Mol Biol 2000, 23:79-85.
118. Halayko A.J., Tran T., Ji S.Y., Yamasaki A., Gosens R. Airway smooth muscle phenotype and function: interactions with current asthma therapies. Curr Drug Targets 2006, 7:525-540.
119. Hirota J.A., Nguyen T.T., Schaafsma D., Sharma P., Tran T. Airway smooth muscle in asthma: phenotype plasticity and function. Pulm Pharmacol Ther 2009, 22:370-378.
120. Halayko A.J., Salari H., Ma X., Stephens N.L. Markers of airway smooth muscle cell phenotype. Am J Physiol 1996, 270:L1040-L1051.
121. Liu H.W., Halayko A.J., Fernandes D.J., Harmon G.S., McCauley J.A., Kocieniewski P., et al. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor. Am J Respir Cell Mol Biol 2003, 29:39-47.
122. Miano J.M., Long X., Fujiwara K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 2007, 292:C70-C81.
123. Blaker A.L., Taylor J.M., Mack C.P. PKA-dependent phosphorylation of serum response factor inhibits smooth muscle-specific gene expression. Arterioscler Thromb Vasc Biol 2009, 29:2153-2160.
124. Davis A., Hogarth K., Fernandes D., Solway J., Niu J., Kolenko V., et al. Functional significance of protein kinase A activation by endothelin-1 and ATP: negative regulation of SRF-dependent gene expression by PKA. Cell Signal 2003, 15:597-604.
125. Roscioni S.S., Dekkers B.G., Prins A.G., Menzen M.H., Meurs H., Schmidt M., et al. cAMP inhibits modulation of airway smooth muscle phenotype via the exchange protein activated by cAMP (Epac) and protein kinase A. Br J Pharmacol 2011, 162:193-209.
126. Sears M.R., Taylor D.R., Print C.G., Lake D.C., Li Q.Q., Flannery E.M., et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990, 336:1391-1396.
127. Johnson M. The β-adrenoceptor. Am J Respir Crit Care Med 1998, 158:S146-S153.
128. Laporte J.C., Moore P.E., Baraldo S., Jouvin M.H., Church T.L., Schwartzman I.N., et al. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 2001, 164:141-148.
129. Nogami M., Romberger D.J., Rennard S.I., Toews M.L. TGF-beta 1 modulates beta-adrenergic receptor number and function in cultured human tracheal smooth muscle cells. Am J Physiol 1994, 266:L187-L191.
130. Hakonarson H., Herrick D.J., Serrano P.G., Grunstein M.M. Mechanism of cytokine-induced modulation of beta-adrenoceptor responsiveness in airway smooth muscle. J Clin Invest 1996, 97:2593-2600.
131. Benovic J.L., Pike L.J., Cerione R.A., Staniszewski C., Yoshimasa T., Codina J., et al. Phosphorylation of the mammalian beta-adrenergic receptor by cyclic AMP-dependent protein kinase. Regulation of the rate of receptor phosphorylation and dephosphorylation by agonist occupancy and effects on coupling of the receptor to the stimulatory guanine nucleotide regulatory protein. J Biol Chem 1985, 260:7094-7101.
132. Belvisi M.G., Saunders M.A., Haddad el B., Hirst S.J., Yacoub M.H., Barnes P.J., et al. Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol 1997, 120:910-916.
133. 2AR-adenylyl cyclase pathway in human airway smooth muscle. Am J Respir Cell Mol Biol 1998, 19:338-348.
134. Deshpande D.A., Theriot B.S., Penn R.B., Walker J.K. β-Arrestins specifically constrain β2-adrenergic receptor signaling and function in airway smooth muscle. FASEB J 2008, 22:2134-2141.
135. Penn R.B., Pascual R.M., Kim Y.M., Mundell S.J., Krymskaya V.P., Panettieri R.A., et al. Arrestin specificity for G protein-coupled receptors in human airway smooth muscle. J Biol Chem 2001, 276:32648-32656.
136. 2-adrenergic receptor physiologic signaling. Proc Natl Acad Sci U S A 2009, 106:15007-15012.
137. 2-Adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists. J Biol Chem 1997, 272:23871-23879.
138. 2-adrenoceptor. Br J Pharmacol 1998, 123:701-711.
139. 2-Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A 2009, 106:2435-2440.
140. Nguyen L.P., Omoluabi O., Parra S., Frieske J.M., Clement C., Ammar-Aouchiche Z., et al. Chronic exposure to β-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol 2008, 38:256-262.
141. Sears M.R. Adverse effects of β-agonists. J Allergy Clin Immunol 2002, 110:S322-S328.